0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Critique |

Bile Leakage and Liver Resection: Where Is the Risk?—Invited Critique

Richard J. Bold, MD
Arch Surg. 2006;141(7):695. doi:10.1001/archsurg.141.7.695.
Text Size: A A A
Published online

Extract

Capussotti et al review the incidence of bile leakage complicating liver surgery in 610 patients who underwent a variety of hepatic resections for various indications. They observed a low incidence of this complication (22 [3.6%] of 610 patients), although it was associated with more than doubling the length of hospitalization but was not associated with increased secondary morbidity or mortality. The authors examined a variety of patient, disease, and technical factors associated with the development of this operative complication; resection of segment 4 and the diagnosis of peripheral cholangiocarcinoma were associated with an increased risk of bile leakage, whereas treatment of the cut hepatic surface with fibrin glue was associated with a decreased risk. The authors conducted the study to identify risk factors that could be modified and therefore reduce the incidence of this complication. Unfortunately, 2 of the 3 risk factors (namely, the diagnosis of peripheral cholangiocarcinoma and resection of segment 4) cannot be altered by the surgeon to reduce the risk of bile leakage. Interestingly, fibrin glue was applied to the cut hepatic surface as a hemostatic agent, without intent to address bile leakage, although its use apparently facilitated the closure of bile ducts that may have been responsible for postoperative bile leakage. Are these data sufficient to warrant the routine use of fibrin glue as a biliary sealant? The answer is clearly no. Even with the use of fibrin sealant, bile leakage still developed in 2.2% of patients compared with 6.2% in patients who were not treated with fibrin glue. Furthermore, it is not reported whether this reduced incidence was associated with altering the sequelae of this complication—the added length of hospitalization. Perhaps fibrin glue should be considered in the patients at highest risk for bile leakage (resection for peripheral cholangiocarcinoma or involving segment 4), although the clinical effect remains unknown.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();